Bakkt, Inc. 8-K

What Happened
Bakkt, Inc. filed an 8-K on June 4, 2026 reporting that, following its November 21, 2025 election to subscribe, the Preferential Issue Committee of Transchem Ltd. approved the allotment of 47,500,000 warrants to Bakkt Opco Holdings, LLC on June 3, 2026. Bakkt paid $9,409,784 to purchase these warrants, which the filing says is equal to 25% of the total subscription amount. The warrants were issued under a preferential allotment and entitle the holder to acquire ordinary shares of Transchem in accordance with their terms. Transchem is an Indian company listed on BSE Ltd.

Key Details

• Allotment approved by Transchem’s Preferential Issue Committee on June 3, 2026.
• 47,500,000 warrants issued to Bakkt Opco Holdings, LLC.
• Bakkt paid $9,409,784 for the warrants (reported as 25% of the total subscription amount).
• The warrants permit acquisition of Transchem ordinary shares per their terms; exercise price/timing not detailed in this filing.

Why It Matters
This filing documents a material investment by Bakkt into Transchem via warrants, representing deployment of roughly $9.41 million of capital and giving Bakkt the potential to convert those warrants into equity in the future. For retail investors, the item is important because it changes Bakkt’s investment exposure and may affect future reported assets or dilution depending on exercise of the warrants. The 8-K does not disclose exercise price or schedule, so watch for future disclosures for details on potential share issuances, exercise terms, or additional funding.